1-3 of 3
Renier J. Brentjens
Close
Sort by
Journal Articles

Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells

Clinical Trials & Observations
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R. Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynn Silverberg, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Sean M. Devlin, Claudia Diamonte, Sergio Giralt, Elizabeth F. Halton, Tania Jain, Molly Maloy, Elena Mead, Maria Lia Palomba, Josel Ruiz, Bianca Santomasso, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Jae H. Park, Lucrecia Yanez San Segundo, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3397–3406.
https://doi.org/10.1182/bloodadvances.2020003885
Published: 2021
Includes: Supplemental data
Journal Articles

Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management

Clinical Trials & Observations
Martina Pennisi, Tania Jain, Bianca D. Santomasso, Elena Mead, Kitsada Wudhikarn, Mari Lynne Silverberg, Yakup Batlevi, Roni Shouval, Sean M. Devlin, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Claudia Diamonte, Sergio Giralt, Elizabeth F. Halton, Molly Maloy, Maria Lia Palomba, Miriam Sanchez-Escamilla, Craig S. Sauter, Michael Scordo, Gunjan Shah, Jae H. Park, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2020) 4 (4): 676–686.
https://doi.org/10.1182/bloodadvances.2019000952
Published: 2020
Journal Articles

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

Clinical Trials & Observations
Peter G. Maslak, Tao Dao, Yvette Bernal, Suzanne M. Chanel, Rong Zhang, Mark Frattini, Todd Rosenblat, Joseph G. Jurcic, Renier J. Brentjens, Maria E. Arcila, Raajit Rampal, Jae H. Park, Dan Douer, Laura Katz, Nicholas Sarlis, Martin S. Tallman, David A. Scheinberg
Journal: Blood Advances
Blood Adv (2018) 2 (3): 224–234.
https://doi.org/10.1182/bloodadvances.2017014175
Published: 2018
Includes: Supplemental data